Indoco Remedies Limited has scheduled a meeting of the Board of Directors to be held on Tuesday, 27th October, 2026. The primary agenda of the meeting is to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September, 2026.
The company also confirmed the continuation of the trading window closure for dealing in Equity Shares of Indoco Remedies Limited. The trading window remains closed for Designated Persons and their immediate relatives until 29th October, 2026, which represents 48 hours after the declaration of the Un-Audited Standalone and Consolidated Financial Results. This closure was initially intimated via notice dated 28th September, 2026.
The document is signed by Ramanathan Hariharan, Company Secretary & Head Legal, and was digitally signed on 14th October, 2026 at 15:14:01 +05:30.